Fundz

Freenome Appoints Aaron Elliott as Chief Executive Officer

PUBLIC · FRNMApr 09, 2025

Position

Chief Executive Officer

Company

Freenome

Aaron Elliott
aaron.elliott@freenome.com
BrisbaneBiotechnologyHealth CareScience And EngineeringVenture CapitalLife Science

Description

Freenome has announced the appointment of Aaron Elliott, Ph.D., as its new chief executive officer. With nearly 20 years of specialized experience in the diagnostics industry, Aaron is expected to drive the launch of the company’s first colorectal cancer screening blood test.

Quick answer

Freenome Appoints Aaron Elliott as Chief Executive Officer (April 9, 2025). Freenome is based in Brisbane, California, United States.

Who is the new Chief Executive Officer at Freenome?
Freenome named Aaron Elliott Chief Executive Officer, announced April 9, 2025.
What did Freenome announce on April 9, 2025?
Freenome has announced the appointment of Aaron Elliott, Ph.D., as its new chief executive officer. With nearly 20 years of specialized experience in the diagnostics industry, Aaron is expected to drive the launch of the company’s first colorectal cancer screening blood test.
What does Freenome do?
Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw.
Where is Freenome based?
Freenome is based in Brisbane, California, United States.
Which similar companies made leadership changes around the same time?
Unlearn (April 8, 2025), Biolyst Scientific (April 4, 2025), LabCentral (April 3, 2025) and Precision AQ (April 25, 2025) also announced leadership changes within 45 days of Freenome.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Venture Capital

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Freenome, and when

A new leader at Freenome brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Freenome raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Freenome, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Freenome. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Freenome

Location

Brisbane, California, United States

About

Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. 1 Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC. Vital Signs: Colorectal Cancer Screening Test Use — United States, 2018. MMWR Morb Mortal Wkly Rep 2020;69:253–259. 2 United States Preventive Services Task Force (USPSTF), "Colorectal Cancer: Screening", May 18, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening SOURCE Freenome Holdings, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Freenome changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Brandon
Likely contact at this company
••••••••@••••••••

See Brandon's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Freenome's next move

Learn about Strategic plan

Freenome changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.